|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2000-11-7
|
|
pubmed:abstractText |
Clinical experience suggests that 6-mercaptopurine (6-MP) is effective therapy for children with active steroid-dependent Crohn's disease (CD). We report the results of a prospective, placebo-controlled, multicenter trial evaluating the combination of 6-MP and prednisone as therapy for children with newly diagnosed moderate-to-severe CD.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0016-5085
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
119
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
895-902
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11040176-6-Mercaptopurine,
pubmed-meshheading:11040176-Adolescent,
pubmed-meshheading:11040176-Child,
pubmed-meshheading:11040176-Crohn Disease,
pubmed-meshheading:11040176-Disease-Free Survival,
pubmed-meshheading:11040176-Double-Blind Method,
pubmed-meshheading:11040176-Drug Therapy, Combination,
pubmed-meshheading:11040176-Female,
pubmed-meshheading:11040176-Glucocorticoids,
pubmed-meshheading:11040176-Growth,
pubmed-meshheading:11040176-Humans,
pubmed-meshheading:11040176-Immunosuppressive Agents,
pubmed-meshheading:11040176-Male,
pubmed-meshheading:11040176-Prednisone,
pubmed-meshheading:11040176-Prospective Studies
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease.
|
|
pubmed:affiliation |
Department of Pediatrics, North Shore-Long Island Jewish Health System, New York University School of Medicine, Manhasset, New York, USA. jamesm@nshs.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
